- Home
- ENVB vs ELAB Comparison
ENVB vs ELAB Comparison
Compare ENVB & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- ELAB
- Stock Information
- Founded
- ENVB 1994
- ELAB 2020
- Country
- ENVB United States
- ELAB United States
- Employees
- ENVB N/A
- ELAB N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- ELAB
- Sector
- ENVB Health Care
- ELAB
- Exchange
- ENVB Nasdaq
- ELAB Nasdaq
- Market Cap
- ENVB 3.0M
- ELAB 3.2M
- IPO Year
- ENVB N/A
- ELAB 2023
- Fundamental
- Price
- ENVB $0.97
- ELAB $4.78
- Analyst Decision
- ENVB Strong Buy
- ELAB
- Analyst Count
- ENVB 1
- ELAB 0
- Target Price
- ENVB $10.00
- ELAB N/A
- AVG Volume (30 Days)
- ENVB 325.7K
- ELAB 2.4M
- Earning Date
- ENVB 08-14-2025
- ELAB 08-13-2025
- Dividend Yield
- ENVB N/A
- ELAB N/A
- EPS Growth
- ENVB N/A
- ELAB N/A
- EPS
- ENVB N/A
- ELAB N/A
- Revenue
- ENVB N/A
- ELAB N/A
- Revenue This Year
- ENVB N/A
- ELAB N/A
- Revenue Next Year
- ENVB N/A
- ELAB N/A
- P/E Ratio
- ENVB N/A
- ELAB N/A
- Revenue Growth
- ENVB N/A
- ELAB N/A
- 52 Week Low
- ENVB $0.85
- ELAB $4.29
- 52 Week High
- ENVB $8.33
- ELAB $1,842.11
- Technical
- Relative Strength Index (RSI)
- ENVB 40.51
- ELAB 36.26
- Support Level
- ENVB $0.85
- ELAB $4.29
- Resistance Level
- ENVB $1.06
- ELAB $4.89
- Average True Range (ATR)
- ENVB 0.10
- ELAB 0.60
- MACD
- ENVB -0.02
- ELAB -0.09
- Stochastic Oscillator
- ENVB 19.34
- ELAB 12.50
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.